Suppr超能文献

EMT 细胞衍生的外泌体 miR-27b-3p 通过调节血管通透性促进结直肠癌中循环肿瘤细胞介导的转移。

EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer.

机构信息

Department of Gastrointestinal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.

Department of Gastric and Colorectal Surgical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.

出版信息

Clin Transl Med. 2021 Dec;11(12):e595. doi: 10.1002/ctm2.595.

Abstract

BACKGROUND

Metastasis is the main cause of death in colorectal cancer (CRC). Circulating tumour cells (CTCs) are regarded as the precursor cells of metastasis. The CTCs, which underwent epithelial-mesenchymal transition (EMT), are associated with metastasis and responsible for poor prognosis. EMT cancer cells modulate endothelial permeability in the invasive front and facilitate cancer cell intravasation, resulting in CTCs-mediated distant metastasis. Exosomes derived from cancer cells are key mediators of cancer-host intercommunication. However, the mechanism by which EMT-tumour cells-derived exosomes modulate vascular permeability and promote CTCs generation has remained unclear.

METHODS

Exosomes isolation and purification were conducted by ultra-centrifugation. Exosomal miRNA was identified by sequencing followed by quantitative PCR. In vitro co-culture assay experiments were conducted to evaluate the effect of exosomal miR-27b-3p on the permeability of blood vessel endothelium. Dual-luciferase reporter assay, chromatin immunoprecipitation (ChIP) and RNA immunoprecipitation (RIP) were performed to investigate the underlying mechanism by which miR-27b-3p is packaged into exosomes. A mouse model was established to determine the role of exosomal miR-27b-3p in blood vessel permeability modulation in vivo.

RESULTS

We found that EMT-CRC cells attenuate the blood vessel barrier by transferring miR-27b-3p to human umbilical vein endothelial cells (HUVECs) in exosomes. Mechanically, miR-27b-3p atteuated the expression of vascular endothelial cadherin (VE-Cad) and p120 at the post-transcriptional level by binding to 3'-untranslated region of VE-Cad and p120 directly. The packaging of miR-27b-3p into exosomes was induced by heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), which activated by STAT3. Clinically, miR-27b-3p up-regulated in CRC tissues. Plasma exosomal miR-27b-3p was positively correlated with malignant progression and CTC count in CRC patients. Our study reveals a novel mechanism by which EMT-CRC cells promote metastasis, increasing blood vessel permeability and facilitating the generation of CTCs.

CONCLUSION

Exosomal miR-27b-3p secreted by EMT-CRC cells increases blood vessel permeability and facilitates the generation of CTCs. Exosomal miR-27b-3p may become a promising biomarker for CRC metastasis.

摘要

背景

转移是结直肠癌(CRC)死亡的主要原因。循环肿瘤细胞(CTC)被认为是转移的前体细胞。经历上皮-间充质转化(EMT)的 CTC 与转移有关,并导致预后不良。EMT 癌细胞在侵袭前沿调节血管通透性,并促进癌细胞浸润,从而导致 CTC 介导的远处转移。源自癌细胞的外泌体是癌症-宿主相互交流的关键介质。然而,EMT 肿瘤细胞衍生的外泌体如何调节血管通透性并促进 CTC 产生的机制尚不清楚。

方法

通过超速离心分离和纯化外泌体。通过测序和定量 PCR 鉴定外泌体中的 miRNA。体外共培养实验评估外泌体 miR-27b-3p 对血管内皮通透性的影响。双荧光素酶报告基因实验、染色质免疫沉淀(ChIP)和 RNA 免疫沉淀(RIP)实验用于研究 miR-27b-3p 被包装到外泌体中的潜在机制。建立小鼠模型以确定外泌体 miR-27b-3p 在体内调节血管通透性中的作用。

结果

我们发现 EMT-CRC 细胞通过外泌体将 miR-27b-3p 转移到人脐静脉内皮细胞(HUVEC)中,从而减弱血管屏障。在机制上,miR-27b-3p 通过直接结合 VE-Cad 和 p120 的 3'-非翻译区,在转录后水平下调 VE-Cad 和 p120 的表达。miR-27b-3p 的包装由异质核核糖核蛋白 A1(hnRNPA1)诱导,hnRNPA1 由 STAT3 激活。临床上,CRC 组织中 miR-27b-3p 上调。CRC 患者血浆外泌体 miR-27b-3p 与恶性进展和 CTC 计数呈正相关。我们的研究揭示了 EMT-CRC 细胞促进转移的新机制,增加血管通透性并促进 CTC 的产生。

结论

EMT-CRC 细胞分泌的外泌体 miR-27b-3p 增加血管通透性并促进 CTC 的产生。外泌体 miR-27b-3p 可能成为 CRC 转移有前途的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b4/8694332/1f7b85eefc5a/CTM2-11-e595-g007.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验